Literature DB >> 11902593

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].

J H Noseworthy, G C Ebers, M K Vandervoort, R E Farquhar, E Yetisir, R Roberts.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11902593

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Authors:  J M Burton; S Kimball; R Vieth; A Bar-Or; H-M Dosch; R Cheung; D Gagne; C D'Souza; M Ursell; P O'Connor
Journal:  Neurology       Date:  2010-04-28       Impact factor: 9.910

2.  Planning a clinical research study.

Authors:  Simon Chan; Anders Jönsson; Mohit Bhandari
Journal:  Indian J Orthop       Date:  2007-01       Impact factor: 1.251

Review 3.  Efficacy of splint therapy for the management of temporomandibular disorders: a meta-analysis.

Authors:  Chao Zhang; Jun-Yi Wu; Dong-Lai Deng; Bing-Yang He; Yuan Tao; Yu-Ming Niu; Mo-Hong Deng
Journal:  Oncotarget       Date:  2016-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.